Amkay Products (BSE 544169)₹55.00+2.80%Medical Equipment & Supplies
In the Mar 2026 quarter (standalone), Amkay Products reported sales of ₹19.04 Cr, down 7.4% from Mar 2025, and net profit of ₹0.35 Cr, down 77.0% year on year. For the year to Mar 2026, sales were ₹42.07 Cr and net profit ₹2.32 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 14.40 | 16.71 | 17.86 | 20.57 | 23.04 | 19.04 |
| Expenses | 12.56 | 15.10 | 15.43 | 18.78 | 19.99 | 18.10 |
| Operating Profit | 1.78 | 1.53 | 2.38 | 1.73 | 2.96 | 0.86 |
| OPM % | 12.5% | 9.3% | 13.4% | 8.5% | 12.9% | 4.6% |
| Other Income | 0.47 | 0.75 | 0.72 | 0.58 | 0.38 | 0.27 |
| Interest | 0.23 | 0.27 | 0.17 | 0.13 | 0.24 | 0.17 |
| Depreciation | 0.27 | 0.31 | 0.35 | 0.50 | 0.44 | 0.47 |
| Profit before tax | 1.78 | 1.73 | 2.61 | 1.71 | 2.69 | 0.52 |
| Tax % | 26.7% | 23.4% | 30.1% | 10.7% | 26.9% | 33.4% |
| Net Profit | 1.31 | 1.34 | 1.84 | 1.52 | 1.98 | 0.35 |
| EPS (Rs) | 2.03 | 2.08 | 2.10 | 1.73 | 2.27 | 0.38 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 26.45 | 40.68 | 36.51 | 27.92 | 31.11 | 38.43 | 42.07 |
| Expenses | 24.76 | 36.05 | 33.72 | 24.87 | 27.66 | 34.20 | 38.07 |
| Operating Profit | 1.58 | 4.48 | 2.68 | 2.92 | 3.32 | 4.12 | 3.84 |
| OPM % | 6.0% | 11.1% | 7.4% | 10.6% | 10.8% | 10.8% | 9.2% |
| Other Income | 0.03 | 0.09 | 0.28 | 0.45 | 1.24 | 1.31 | 0.66 |
| Interest | 0.46 | 0.23 | 0.40 | 0.48 | 0.51 | 0.31 | 0.42 |
| Depreciation | 0.53 | 0.52 | 0.55 | 0.70 | 0.57 | 0.84 | 0.89 |
| Profit before tax | 0.65 | 3.85 | 2.04 | 2.24 | 3.51 | 4.31 | 3.22 |
| Tax % | 25.1% | 25.1% | 28.2% | 30.6% | 25.0% | 22.4% | 27.8% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.24 | 0.71 | 0.81 | 0.00 |
| Net Profit | 0.49 | 2.89 | 1.48 | 1.56 | 2.64 | 3.35 | 2.32 |
| EPS (Rs) | 172.59 | 1,035.47 | 529.06 | 557.73 | 4.11 | 3.84 | 2.66 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.29 | 0.29 | 0.29 | 0.29 | 6.36 | 8.66 | 8.66 |
| Reserves | 2.43 | 5.68 | 5.93 | 7.10 | 3.64 | 15.41 | 17.71 |
| Borrowings | 1.63 | 0.43 | 4.33 | 4.70 | 5.47 | 2.64 | 3.93 |
| Other Liabilities | 2.53 | 7.66 | 5.24 | 2.88 | 2.46 | 3.16 | 2.99 |
| Total Liabilities | 6.88 | 14.06 | 15.79 | 14.97 | 17.93 | 29.87 | 33.29 |
| Fixed Assets | 0.00 | 0.00 | 3.90 | 2.39 | 2.57 | 4.13 | 4.26 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 |
| Investments | 0.00 | 0.39 | 2.78 | 3.61 | 2.56 | 6.84 | 6.48 |
| Other Assets | 6.88 | 13.67 | 9.11 | 8.97 | 12.80 | 18.79 | 22.55 |
| Inventories | 0.22 | 0.30 | 1.99 | 2.62 | 5.62 | 8.14 | 9.66 |
| Trade receivables | 2.27 | 4.49 | 3.64 | 3.71 | 4.00 | 6.02 | 4.94 |
| Cash & equivalents | 0.16 | 0.02 | 0.19 | 0.04 | 0.10 | 1.53 | 3.17 |
| Total Assets | 6.88 | 14.06 | 15.79 | 14.97 | 17.93 | 29.87 | 33.29 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | −0.26 | 0.02 | −0.67 | −0.33 | 1.19 |
| Cash from investing activity | −3.06 | −0.33 | 0.47 | −5.83 | −0.39 |
| Cash from financing activity | 2.58 | 0.30 | 0.23 | 7.58 | 0.87 |
| Net cash flow | −0.73 | −0.02 | 0.07 | 1.44 | 1.65 |
| Capex | 2.14 | 0.01 | 1.15 | 2.74 | 0.89 |
| Free cash flow | −2.39 | 0.00 | −1.81 | −3.04 | 0.27 |
| CFO / OP % | 10.0% | 32.1% | 7.0% | 17.0% | 54.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 31 | 40 | 36 | 48 | 47 | 57 | 43 |
| Inventory days | 6 | 5 | 29 | 48 | 94 | 114 | 126 |
| Days payable | 41 | 82 | 63 | 43 | 33 | 35 | 28 |
| Cash conversion cycle | −6 | −38 | 0 | 51 | 105 | 134 | 139 |
| Working capital days | 11 | −9 | 21 | 54 | 56 | 104 | 96 |
| ROCE % | — | 76.3% | 28.8% | 20.9% | 22.3% | 16.9% | 12.7% |
For the Mar 2026 quarter, Amkay Products reported sales of ₹19.04 Cr, down 7.4% year on year and net profit of ₹0.35 Cr, down 77.0% year on year. The operating margin was 4.6%.
Amkay Products' sales for the year to Mar 2026 were ₹42.07 Cr.
Net profit for the year to Mar 2026 was ₹2.32 Cr. Earnings per share over the same trailing period were ₹2.66.
Amkay Products reported borrowings of ₹3.93 Cr at Mar 2026, against cash and equivalents of ₹3.17 Cr.
Cash from operations was ₹1.19 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.27 Cr.